Tbo-filgrastim

From WikiMD.org
Jump to navigation Jump to search

Tbo-filgrastim

Tbo-filgrastim (/ˈtiːboʊ fɪlˈɡræstɪm/) is a biopharmaceutical drug used to stimulate the production of neutrophils, a type of white blood cell that plays a significant role in the body's response to infection.

Etymology

The name "Tbo-filgrastim" is derived from the original name of the drug, "filgrastim", with the prefix "Tbo-" added to distinguish it from other filgrastim products. "Filgrastim" itself is derived from the term "granulocyte colony-stimulating factor" (G-CSF), which describes the drug's function.

Usage

Tbo-filgrastim is used to treat neutropenia, a condition characterized by an abnormally low number of neutrophils. This condition is often a side effect of chemotherapy treatment for cancer. By stimulating the production of neutrophils, Tbo-filgrastim helps to reduce the risk of infection in patients undergoing chemotherapy.

Related Terms

  • Neutropenia: A condition characterized by an abnormally low number of neutrophils.
  • Neutrophil: A type of white blood cell that plays a significant role in the body's response to infection.
  • Biopharmaceutical: A type of drug produced using biotechnology.
  • Chemotherapy: A type of cancer treatment that uses drugs to kill cancer cells.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski